Effects of Scrophularia extracts on tumor cell proliferation, death and intravasation through lymphoendothelial cell barriers

International Journal of Oncology

Volumn 40, Issue 6, 2012, Pages 2063-2074

  Giessrigl, Benedikt ^a,b   Yazici, Gökhan ^c   Teichmann, Mathias ^a   Kopf, Sabine ^a   Ghassemi, Sara ^d   Atanasov, Atanas G ^b   Dirsch, Verena M ^b   Grusch, Michael ^d   Jäger, Walter ^b   Özmen, Ali ^c   Krupitza, Georg ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c ADNAN MENDERES UNIVERSITY   (Turkey)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cell death; Cell proliferation; Intravasation; Oncogenes; Scrophularia lucida

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PLANT EXTRACT; SCROPHULARIA FLORIBUNDA EXTRACT; SCROPHULARIA LIBANOTICA EXTRACT; SCROPHULARIA LUCIDA EXTRACT; SCROPHULARIA PEREGRINA EXTRACT; SCROPHULARIA PINARDII EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; ATTENUATION; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPH; ONCOGENE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SCROPHULARIA FLORIBUNDA; SCROPHULARIA LIBANOTICA; SCROPHULARIA LUCIDA; SCROPHULARIA PEREGRINA; SCROPHULARIA PINARDII; SCROPHULARIACEAE; SPHEROID CELL; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; LYMPHATIC METASTASIS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NF-KAPPA B; ONCOGENES; PLANT EXTRACTS; PLANTS, MEDICINAL; SCROPHULARIA; SPHEROIDS, CELLULAR;

EID: 84861788398     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1388     Document Type: Article

References (59)

1. Wang MW, Hao X and Chen K: Biological screening of natural products and drug innovation in China. Philos Trans R Soc Lond B Biol Sci 362: 1093-1105, 2007. (Pubitemid 47056805)
2. Gonzales GF and Valerio LG Jr: Medicinal plants from Peru: a review of plants as potential agents against cancer. Anticancer Agents Med Chem 6: 429-444, 2006. (Pubitemid 44377777)
3. Cragg GM and Newman DJ: Plants as a source of anti-cancer agents. J Ethophrmacol 100: 72-79, 2005. (Pubitemid 41073525)
4. Cragg GM and Newman DJ: Antineoplastic agents fom natural sources: achievements and future directions. Expert Opin Investig Drugs 9: 2783-2797, 2000.
5. Newman DJ and Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477, 2007. (Pubitemid 46595760)
6. Baytop T: Türkiyede Bitkiler ile Tedavi. Istanbul University Press, Faculty of Pharmacy, p3255, 1999.
7. Vienna Dioscurides, 6th century, National Library, manuscript collection, Vienna, Austria.
8. Galindez J, Diaz-Lanza AM and Fernandez-Metallano L: Biologically active substances from the genus Scrophularia. Pharmaceutical Biol 40: 45-59, 2002. (Pubitemid 34264345)
9. Çalis I, Gross GA and Sticher O: Phenylpropanoid glycosides isolated from Scrophularia scopolii. Phytochemistry 26: 2057-2061, 1987.
10. Nguyen AT, Fontaine J, Malonne H, Claeys M, Luhmer M and Duez P: A sugar ester and an iridoid glycoside from Scrophularia ningpoensis. Phytochemistry 66: 1186-1191, 2005. (Pubitemid 40728316)
11. Giner RM, Villalba ML, Recio MC, Manez S, Cerda-Nicolas M and Rios JL: Anti-inflammatory glycoterpenoids from Scrophularia auriculata. Eur J Pharmacol 389: 243-252, 2000. (Pubitemid 30109415)
12. Díaz AM, Abad MJ, Fernández L, Silván AM, De Santos J and Bermejo P: Phenylpropanoid glycosides from Scrophularia scorodonia: in vitro anti-inflammatory activity. Life Sci 74: 2515-2526, 2004. (Pubitemid 38317116)
13. Özmen A, Madlener S, Bauer S, Krasteva S, Vonach C, Giessrigl B, Gridling M, Viola K, Stark N, Saiko P, Michel B, Fritzer-Szekeres M, Szekeres T, Askin-Celik T, Krenn L and Krupitza G: In vitro antileukemic activity of the ethno-pharmacological plant Scutellaria orientalis ssp. carica endemic to western Turkey. Phytomedicine 17: 55-62, 2010.
14. Özmen A, Bauer S, Gridling M, Singhuber J, Krasteva S, Madlener S, Vo NTP, Stark N, Saiko P, Fritzer-Szekeres M, Szekeres T, Askin-Celik T, Krenn L and Krupitza G: In vitro antineoplastic activity of the ethno-pharmaceutical plant Hypericum adenotrichum Spach endemic to western Turkey. Oncol Rep 22: 845-852, 2009.
15. Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B, Keller T, Nagy-Bojarszky K, Huttary N, Raab I, Lackner K, Krautgasser K, Schachner H, Kaserer K, Rezar S, Madlener S, Vonach C, Davidovits A, Nosaka H, Hämmerle M, Viola K, Dolznig H, Schreiber M, Nader A, Mikulits W, Gnant M, Hirakawa S, Detmar M, Alitalo K, Nijman S, Offner F, Maier TJ, Steinhilber D and Krupitza G: Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest 121: 2000-2012, 2011.
16. Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Kalt R, Krieger S, Vo NTP, Madlener S, Bauer S, Marian B, Hämmerle M, Kretschy N, Teichmann M, Hantusch B, Stary S, Unger C, Seelinger M, Eger A, Mader R, Jäger W, Schmidt W, Grusch M, Dolznig H, Mikulits W and Krupitza G: NF-.B mediates the12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Br J Cancer 105: 263-271, 2011.
17. Madlener S, Saiko P, Vonach C, Viola K, Huttary N, Stark N, Popescu R, Gridling M, Vo NTP, Herbacek I, Davidovits A, Giessrigl B, Venkateswarlu S, Geleff S, Jäger W, Grusch M, Kerjaschki D, Mikulits W, Golakoti T, Fritzer-Szekeres M, Szekeres T and Krupitza G: Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro. Br J Cancer 102: 1361-1370, 2010.
18. Maier S, Strasser S, Saiko P, Leisser C, Sasgary S, Grusch M, Madlener S, Bader Y, Hartmann J, Schott H, Mader RM, Szekeres T, Fritzer-Szekeres M and Krupitza G: Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC. Apoptosis 11: 427-440, 2006.
19. Strasser S, Maier S, Leisser C, Saiko P, Madlener S, Bader Y, Bernhaus A, Gueorguieva M, Richter S, Mader RM, Wesierska- Gadek J, Schott H, Szekeres T, Fritzer-Szekeres M and Krupitza G: 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2. Differentiation 74: 488-498, 2006. (Pubitemid 44922494)
20. Grusch M, Fritzer-Szekeres M, FuhrmannG, Rosenberger G, Luxbacher C, Elford HL, Smid K, Peters GJ, Szekeres T and Krupitza G: Activation of caspases and induction of apoptosis by amidox and didox. Exp Haematol 29: 623-632, 2001.
21. Grusch M, Polgar D, Gfatter S, Leuhuber K, Huettenbrenner S, Leisser C, Fuhrmann G, Kassie F, Steinkellner H, Smid K, Peters GJ, Jayaram H, Klepal T, Szekeres T, Knasmüller S and Krupitza G: Maintainance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ 9: 169-178, 2002. (Pubitemid 34144776)
22. Hüttenbrenner S, Maier S, Leisser C, Polgar D, Strasser S, Grusch M and Krupitza G: The evolution of cell death programs as prerequisites of multicellularity. Rev Mutat Res 543: 235-249, 2003. (Pubitemid 36645082)
23. Madlener S, Svacinová J, Kitner M, Kopecky J, Eytner R, Lackner A, Vo NTP, Frisch R, Grusch M, de Martin R, Dolezal K, Strnad M and Krupitza G: In vitro anti-inflammatory and anticancer activities of extracts of Acalypha alopecuroidea (Euphorbiaceae). Int J Oncol 35: 881-891, 2009.
24. Gridling M, Stark N, Madlener S, Lackner A, Popescu R, Benedek B, Diaz R, Tut FM, Vo NTP, Huber D, Gollinger M, Saiko P, Özmen A, Mosgoeller W, de Martin R, Eytner R, Wagner KH, Grusch M, Fritzer-Szekeres M, Szekeres T, Kopp B, Frisch R and Krupitza G: In vitro anti-cancer activity of two ethno-pharmacological healing plants from Guatemala Pluchea odorata and Phlebodium decumanum. Int J Oncol 34: 1117-1128, 2009.
25. Biroccio A, del Bufalo D, Ricca A, D'Angelo C, D'Orazi G, Sacchi A, Soddu S and Zupi G: Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule. Gene Ther 6: 1064-1072, 1999. (Pubitemid 29295212)
26. Park KS, Jeon SH, Oh JW and Choi KY: P21Cip/WAF1 activation is an important factor for the ERK pathway dependent anti-proliferation of colorectal cancer cells. Exp Mol Med 36: 557-562, 2004. (Pubitemid 40129178)
27. Facchinetti MM, De Siervi A, Toskos D and Senderowicz AM: UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal regulated kinase pathway. Cancer Res 64: 3629-3637, 2004. (Pubitemid 38657942)
28. Ebner HL, Blatzer M, Nawaz M and Krumschnabel G: Activation and nuclear translocation of Erk in response to ligand-dependent and -independent stimuli in liver and gill cells from rainbow trout. J Exp Biol 210: 1036-1045, 2007. (Pubitemid 46650607)
29. Lee CM, Onésime D, Reddy CD, Dhanasekaran N and Reddy EPJLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci USA 99: 14189-14194, 2002. (Pubitemid 35257647)
30. Zervos AS, Faccio L, Gatto JP, Kyriakis JM and Brent R: Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci USA 92: 10531-1054, 1995.
31. Donzelli M and Draetta GF: Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 4: 671-677, 2003. (Pubitemid 36974751)
32. Falck J, Mailand N, Syljuasen RG, Bartek J and Lukas J: The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410: 842-847, 2001. (Pubitemid 32303786)
33. Baudino TA and Cleveland JL: The Max network gone mad. Mol Cell Biol 21: 691-702, 2001. (Pubitemid 32104718)
34. Dang CV: C-Myc target genes involved in cell growth, apoptosis and metabolism. Mol Cell Biol 19: 1-11, 1999.
35. Milde-Langosch K: The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 41: 2449-2461, 2005
36. Tulchinsky E: Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol 15: 921-928, 2000.
37. Fernandes-Alnemri T, Litwack G and Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-concerting enzyme. J Biol Chem 269: 30761-30764, 1994. (Pubitemid 24377553)
38. Germain M, Affar EB, d'Amours D, Dixit VM, Salvesen GS and Poirier GG: Cleavage of poly(ADP-ribose)polymerase during apoptosis. J Biol Chem 274: 28379-28384, 1999.
39. Shah GM, Shah RG and Poirier GG: Different cleavage pattern for poly(ADP-Ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem Biophys Res Commun 229: 838-844, 1996. (Pubitemid 27035804)
40. Casiano CA, Ochs RL and Tan EM: Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 5: 183-190, 1998. (Pubitemid 28356555)
41. Gobell S, Boucher CC, Nadeau D and Poirier GG: Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ 8: 588-594, 2001. (Pubitemid 32586595)
42. Fritzer-Szekeres M, Grusch M, Luxbacher C, Horvath Z, Krupitza G, Elford HL and Szekeres T: Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells. Exp Hematol 28: 924-930, 2000.
43. Piperno G and Fuller M: Monoclonal antibodies specific for an acetylated form of alpha-tubulin recognize the antigen in cilia and flagella from a variety of organisms. J Cell Biol 101: 2085-2094, 1985. (Pubitemid 16169938)
44. Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB and Orr GA: Insights into the mechanism of microtubule stabilization by taxol. Proc Natl Acad Sci USA 103: 10166-10173, 2006. (Pubitemid 44051138)
45. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
46. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
47. Brown M, Cohen J, Arun D, Chen Z and van Waes C: NF-kappa B in carcinoma therapy and prevention. Expert Opin Targets 12: 1109-1122, 2008.
48. Flister MJ, Wilber A, Hall KL, Iwata C, Miyazona K, Nisato RE, Pepper MS, Zawieja DC and Ran S: Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Pro1. Blood 115: 418-429, 2010.
49. Adhikary S and Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645, 2005. (Pubitemid 41081267)
50. Gauwerky CE and Croce CM: Chromosomal translocations in leukaemia. Semin Cancer Biol 4: 333-340, 1993. (Pubitemid 2028597)
51. De Alboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L and Rickert R: Analysis of c-myc function in normal cells via conditional gene-target mutation. Immunity 14: 45-55, 2001. (Pubitemid 32144686)
52. Prathapam T, Tegen S, Oskarsson T, Trumpp A and Martin GS: Activated Src abrogates the myc requirement for the G0/G1 transition but not for the G1/S transition. Proc Natl Acad Sci USA 103: 2695-2700, 2006.
53. Wang H, Mannava S, Grachtchouk V, Zhuang D, Soengas MS, Gudkov AV, Prochownik EV and Nikiforov MA: c-Myc depletion inhibits proliferation of human tumor cells at various stages of cell cycle. Oncogene 27: 1905-1915, 2008. (Pubitemid 351430817)
54. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC, Elia A, Kress TR, Dickens M, Clemens MJ, Heery DM, Gaestel M, Eilers M, Willis AE and Bushell M: p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci USA 107: 5375-5380, 2010.
55. Krupitza G, Harant H, Dittrich E, Szekeres T, Huber H and Dittrich C: Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells. Carcinogenesis 16: 1199-1205, 1995.
56. Krupitza G, Grill S, Harant H, Hulla W, Szekeres T, Huber H and Dittrich C: Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells. Br J Cancer 73: 433-438, 1996. (Pubitemid 26055311)
57. Van Zijl F, Krupitza G and Mikulits W: Initial steps of metastasis: cell i nvasion a nd endothelial t ransmigration. Mutat Res 728: 23-34, 2011.
58. Hajiaghaee R, Monsef-Esfahani HR, Khorramizadeh MR, Saadat F, Shahverdi AR and Attar F: Inhibitory effect of aerial parts of Scrophularia striata on matrix metalloproteinases expression. Phytother Res 21: 1127-1129, 2007.
59. Eger A and Mikulits W: Models of epithelial-mesenchymal transition. Drug Disc Today; Disease models 2: 57-63, 2005.